The global cancer/tumor profiling market is projected to grow at a CAGR of 11% during 2019 to 2024. The growth of cancer/tumor profiling market is driven by growing demand for cancer profiling method by oncologists to diagnose cancers, rise in adoption of cancer biomarkers for tumor profiling, increasing utility of biomarkers in tumor profiling, increasing cancer patients across the globe, and growth in use of next-generation sequencing technique for cancer profiling.
Some of the Key Questions answered in this exclusive report are:
Q.1 What are some of the
most promising potential, high-growth opportunities for the global cancer/tumor
profiling market by application (clinical applications and research
applications), technology (immunoassays, hybridization, next-generation
sequencing, mass spectroscopy, and other technologies (pyrosequencing and
sanger sequencing), cancer type (breast cancer, lung cancer, colorectal cancer,
prostate cancer, melanoma cancer, and other cancer types (non-hodgkin’s
lymphoma, melanoma, leukemia, thyroid, bladder, and kidney)), biomarker type
(genetic biomarkers, protein biomarkers, and other biomarkers), and region
(North America, Europe, Asia-Pacific, and ROW)?
Q.2 Which segments will
grow at a faster pace and why?
Q.3 What are the
business risks and threats to the cancer/tumor profiling market?
Q.4 What are some
changing demands of customers in the cancer/tumor profiling market?
Q.5 What are the new
developments in the cancer/tumor profiling market? Which companies are leading
these developments?
Q.6 What strategic
initiatives are being implemented by key players for business growth?
Q.7 What are some of the
competitive products and processes in this cancer/tumor profiling area and how
big of a threat do they pose for loss of market share via product substitution?
Q.8 What M&A activity has occurred in the last 5 years in this cancer/tumor profiling market?
Download Brochure of this report by
clicking on https://www.lucintel.com/cancer-tumor-profiling-market.aspx
Market Segmentation:
Based on technology, the
cancer/tumor profiling market is segmented into immunoassays, hybridization,
next-generation sequencing, mass spectroscopy, and other technologies
(pyrosequencing and sanger sequencing). The sequencing segment accounted for
the largest share of the market in 2020 and is expected to register the highest
CAGR during the forecast period.
North America will
remain the largest region over the forecast period due to increasing
investments for the discovery and development of biomarkers, growing demand for
personalized therapeutics, rising adoption of advanced omics technologies for
cancer research, and the increasing use of biomarkers for drug development.
Key Players in the
cancer/tumor profiling market are Illumina, Qiagen, HTG Molecular Diagnostics,
Genomic Health, Caris Life Sciences, Helomics, Nanostring Technologies, Oxford
Gene Technology, and Ribomed Biotechnologies.
Request Sample Pages by clicking on
https://www.lucintel.com/cancer-tumor-profiling-market.aspx
The report helps stakeholders understand the
pulse of the market and provides them with information on key drivers,
restraints, challenges, and opportunities for market growth. It would also help
to understand the competitors better and gain more insights to improve their
position in the business.
To read more about this market please click on
https://www.lucintel.com/cancer-tumor-profiling-market.aspx
About
Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Brandon
Fitzgerald
Lucintel
Dallas,
Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Liquid
Biopsy Market:
For more details click here https://www.lucintel.com/liquid-biopsy-market.aspx
Medical
Lifting Sling Market:
For more details click here https://www.lucintel.com/medical-lifting-sling-market.aspx
Connected Health Device Market:
For more details click here https://www.lucintel.com/connected-health-device-market.aspx
Diagnostic Imaging Market:
For more details click here https://www.lucintel.com/diagnostic-imaging-market.aspx
Global Medical Battery Market:
For more details click here https://www.lucintel.com/medical-battery-market.aspx
Medical Device Market:
For more details click here https://www.lucintel.com/medical-device-market.aspx
Interventional
Cardiology And Peripheral Vascular Device Market:
For more details click here https://www.lucintel.com/interventional-cardiology-peripheral-vascular-devi.aspx
Wheelchair Market:
For more details click here https://www.lucintel.com/wheelchair-market.aspx
Stretcher
Market:
For more details click here https://www.lucintel.com/stretcher-market.aspx
Coronary Stent Market:
For more details click here https://www.lucintel.com/stents-market.aspx
No comments:
Post a Comment